OC
CELG

Oppenheimer & Co’s Celgene Corp CELG Stock Holding History

Oppenheimer & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-65,713
Closed -$6.53M – 1359
2019
Q3 		$6.53M Sell
65,713
-36,753
-36% -$3.49M 0.18% 131
2019
Q2 		$9.47M Sell
102,466
-36,580
-26% -$3.47M 0.26% 83
2019
Q1 		$13.1M Buy
139,046
+7,554
+6% +$661K 0.35% 62
2018
Q4 		$8.43M Sell
131,492
-19,464
-13% -$1.44M 0.26% 86
2018
Q3 		$13.5M Buy
150,956
+26,591
+21% +$2.35M 0.34% 62
2018
Q2 		$9.88M Sell
124,365
-8,117
-6% -$674K 0.27% 82
2018
Q1 		$11.8M Sell
132,482
-11,618
-8% -$1.12M 0.3% 73
2017
Q4 		$15M Sell
144,100
-11,773
-8% -$1.33M 0.39% 55
2017
Q3 		$22.7M Buy
155,873
+24,482
+19% +$3.33M 0.61% 26
2017
Q2 		$17.1M Buy
131,391
+12,194
+10% +$1.49M 0.47% 38
2017
Q1 		$14.8M Buy
119,197
+23,471
+25% +$2.81M 0.42% 49
2016
Q4 		$11.1M Sell
95,726
-5,774
-6% -$643K 0.32% 70
2016
Q3 		$10.6M Buy
101,500
+7,640
+8% +$827K 0.31% 72
2016
Q2 		$9.26M Sell
93,860
-1,539
-2% -$159K 0.28% 85
2016
Q1 		$9.55M Sell
95,399
-3,587
-4% -$369K 0.29% 82
2015
Q4 		$11.9M Sell
98,986
-3,552
-3% -$411K 0.35% 64
2015
Q3 		$11.1M Sell
102,538
-9,914
-9% -$1.23M 0.34% 61
2015
Q2 		$13M Sell
112,452
-2,553
-2% -$292K 0.36% 56
2015
Q1 		$13.3M Buy
115,005
+8,212
+8% +$981K 0.36% 59
2014
Q4 		$11.9M Sell
106,793
-3,281
-3% -$346K 0.34% 64
2014
Q3 		$10.4M Buy
110,074
+6,605
+6% +$596K 0.31% 67
2014
Q2 		$8.89M Buy
103,469
+13,021
+14% +$990K 0.27% 85
2014
Q1 		$6.31M Buy
90,448
+30,946
+52% +$2.45M 0.19% 128
2013
Q4 		$5.03M Sell
59,502
-1,792
-3% -$142K 0.16% 157
2013
Q3 		$4.72M Buy
61,294
+4,318
+8% +$303K 0.17% 158
2013
Q2 		$3.33M Buy
+56,976
New +$3.43M 0.13% 196

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Oppenheimer & Co's CELG Position: Q4 2019 in Review

Oppenheimer & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 65,713 shares — an estimated $6.53M sold.

Oppenheimer & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $22.7M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Oppenheimer & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Oppenheimer & Co sold 65,713 Celgene Corp shares in Q4 2019, an estimated $6.53M.
  • Oppenheimer & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Oppenheimer & Co's Celgene Corp position peaked at $22.7M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.